Shanghai Sixth People's Hospital
Shanghai, Shanghai Municipality, 200233, China
Location status: Recruiting
NCT Number: NCT06671184
No prior studies have stratified the difficulty of transoral and submental thyroidectomy (TOaST). The investigators aimed to investigate preoperative factors as indicators of difficult TOaSTs and to develop a predictive model accordingly.
Interested in participating?
Request InfoAll sexes
Observational
Shanghai, Shanghai Municipality, 200233, China
Location status: Recruiting
Thyroid cancer is the most common endocrine malignancy, with a female predominance. Thyroidectomy is the main treatment for thyroid cancer, and considering the good prognosis of thyroid cancer, endoscopic thyroid surgery, which avoids neck incision, is being widely used in the clinic in order to improve the life treatment of patients. Among them, endoscopic thyroidectomy with transoral approach has a shorter learning curve because of the short surgical path. However, due to the complex structure of the neck, small space, and rich blood supply of the thyroid gland, surrounded by parathyroid glands and important nerves, endoscopic thyroid is difficult and has a long learning curve. In addition, a series of complications such as haemorrhage, hypoparathyroidism and laryngeal reentrant nerve injury can seriously affect the quality of patient survival. Difficult thyroidectomy is usually characterized by a long operative time, high intraoperative bleeding and a high incidence of postoperative complications. According to the literature, in open thyroid surgery, the degree of difficulty is associated with factors such as goiter, inflammation, and hyperthyroidism. However, the degree of difficulty of thyroidectomy due to various factors varies and is difficult to predict. Surgical difficulty is closely related to the outcome and safety of thyroidectomy, which is an urgent concern for surgeons. And there is no study on the degree of difficulty of transoral and submental endoscopic thyroidectomy, therefore, there is an urgent need for an effective and objective method to determine the preoperative factors affecting the degree of surgical difficulty and to establish a model for validation, so that it can be subsequently replicated in other hospitals.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Age, body mass index, gender, thyroid function parameters, lesion size, lesion location, ultrasound data
Time frame: through study completion, an average of 1 year
impaired vocal cord mobility confirmed by postoperative laryngoscopy
Time frame: through study completion, an average of 1 year
a postoperative parathyroid hormone level of less than 10 pg/ml
Time frame: through study completion, an average of 1 year
a postoperative numbness in the lower lip and submental area
Time frame: through study completion, an average of 1 year
operative time was defined as the duration from incision to closure, and was collected from anesthesia record sheet
Time frame: through study completion, an average of 1 year
days of hospitalization
Time frame: approximately 4 hours after surgery and on postoperative day 1
pain intensity was assessed using a standard visual analogue score, with a score of 0 to 10 corresponding to no pain to the most severe pain
Contact information is provided by the study sponsor or research team.
Shanghai 6th People's Hospital
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06458036
Cancer, Cancer, Thyroid
San Francisco, California, United States
View Trial DetailsNCT05538130
Advanced or Metastatic Solid Tumors, Brain Diseases
Birmingham, Alabama, United States
View Trial DetailsNCT05852223
Differentiated Thyroid Cancer
Pavia, Lombardy, Italy
View Trial DetailsNCT05604963
Differentiated Thyroid Cancer
Crewe, Cheshire, United Kingdom
View Trial Details